Vascular Physician Offer and Report (VAPOR) Trial
VAPOR
1 other identifier
interventional
156
1 country
8
Brief Summary
The purpose of the study is to see if vascular physicians (your provider) using a combination of proven smoking cessation tools in an organized way can help vascular patients quit smoking better than usual. The doctors where you are being treated have been chosen to either provide: the combination therapy of giving you advice, considering prescribing medications to help you quit smoking, and referring you to a phone quitline, or to continue their usual smoking cessation practices (which may include all, some, or none of the treatments above).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2014
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 14, 2014
CompletedFirst Posted
Study publicly available on registry
August 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedJuly 27, 2017
July 1, 2017
1.6 years
August 14, 2014
July 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of the "Offer and Report" protocol for change in smoking status from Baseline Visit to 3 Month Visit
To assess the efficacy of the "Offer and Report" protocol (standardized (1) "very brief advice," (2) referral to telephone-based smoking cessation counseling, and (3) consideration of prescribing nicotine replacement therapy (NRT)) as compared to usual smoking cessation care by vascular physicians in biochemically-validated 3 month smoking cessation rates. A questionnaire will be completed by the patient at the Baseline visit and another questionnaire will be completed at the 3 month visit to assess the change in smoking status.
Change in smoking status from Baseline Visit to 3 Month Visit
Study Arms (2)
Offer and Report Protocol
EXPERIMENTALPhysician advice to stop smoking, referral to state Quitline, and physician considers prescribing nicotine replacement therapy.
Usual Care
NO INTERVENTIONPhysician will follow their institution's standard of care for smoking cessation.
Interventions
Physician advice to stop smoking, referral to state Quitline, and physician considers prescribing nicotine replacement therapy.
Eligibility Criteria
You may qualify if:
- Age \>18
- Current smoker
- Plan to have a Vascular Quality Initiative (VQI) procedure in \> 7 days
You may not qualify if:
- Pregnant Women, Fetuses and Neonates
- Children
- People with impaired decision-making capacity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dartmouth-Hitchcock Medical Centerlead
- Society for Vascular Surgerycollaborator
Study Sites (8)
UF Health
Gainesville, Florida, 32610-0128, United States
Northwestern Memorial
Chicago, Illinois, 60611, United States
University Health
Shreveport, Louisiana, 71130, United States
Boston Medical Center
Boston, Massachusetts, 02118, United States
UMASS Memorial Medical Center
Worcester, Massachusetts, 01655, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03766, United States
Roper Hospital
Charleston, South Carolina, 29401, United States
University of Utah Hospital
Salt Lake City, Utah, 84132, United States
Related Publications (1)
Spangler EL, Brooke BS, Beck AW, Hoel A, Farber A, Goodney PP; VAPOR Trial Investigators. Design and initial enrollment in the Vascular Physicians Offer and Report (VAPOR) trial. J Vasc Surg. 2016 Apr;63(4):1121-5.e2. doi: 10.1016/j.jvs.2015.12.026.
PMID: 27016862DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip Goodney, MD, MS
Dartmouth-Hitchcock Medical Center
- PRINCIPAL INVESTIGATOR
Alik Farber, MD
Boston Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2014
First Posted
August 20, 2014
Study Start
August 1, 2014
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
July 27, 2017
Record last verified: 2017-07